New Tools on the Horizon: Excitement Around CT-155 and Schizophrenia Care
The upcoming presentation of Boehringer Ingelheim’s CT-155 at the NEI Spring Congress marks a promising shift in schizophrenia care, targeting cognitive and functional recovery through an innovative prescription digital therapeutic